These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35636724)

  • 1. Prospects of halofuginone as an antiprotozoal drug scaffold.
    Gill J; Sharma A
    Drug Discov Today; 2022 Sep; 27(9):2586-2592. PubMed ID: 35636724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Halofuginone - the multifaceted molecule.
    Pines M; Spector I
    Molecules; 2015 Jan; 20(1):573-94. PubMed ID: 25569515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chemistry and biology of febrifugine and halofuginone.
    McLaughlin NP; Evans P; Pines M
    Bioorg Med Chem; 2014 Apr; 22(7):1993-2004. PubMed ID: 24650700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Phytophthora Activity of Halofuginone and the Corresponding Mode of Action.
    Zhang S; Cai J; Xie Y; Zhang X; Yang X; Lin S; Xiang W; Zhang J
    J Agric Food Chem; 2022 Oct; 70(39):12364-12371. PubMed ID: 36126316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of Prolyl-tRNA Synthetase-Halofuginone Complex Provides Basis for Development of Drugs against Malaria and Toxoplasmosis.
    Jain V; Yogavel M; Oshima Y; Kikuchi H; Touquet B; Hakimi MA; Sharma A
    Structure; 2015 May; 23(5):819-829. PubMed ID: 25817387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase.
    Keller TL; Zocco D; Sundrud MS; Hendrick M; Edenius M; Yum J; Kim YJ; Lee HK; Cortese JF; Wirth DF; Dignam JD; Rao A; Yeo CY; Mazitschek R; Whitman M
    Nat Chem Biol; 2012 Feb; 8(3):311-7. PubMed ID: 22327401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and Coccidiosis.
    Jain V; Yogavel M; Kikuchi H; Oshima Y; Hariguchi N; Matsumoto M; Goel P; Touquet B; Jumani RS; Tacchini-Cottier F; Harlos K; Huston CD; Hakimi MA; Sharma A
    Structure; 2017 Oct; 25(10):1495-1505.e6. PubMed ID: 28867614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs.
    Herman JD; Pepper LR; Cortese JF; Estiu G; Galinsky K; Zuzarte-Luis V; Derbyshire ER; Ribacke U; Lukens AK; Santos SA; Patel V; Clish CB; Sullivan WJ; Zhou H; Bopp SE; Schimmel P; Lindquist S; Clardy J; Mota MM; Keller TL; Whitman M; Wiest O; Wirth DF; Mazitschek R
    Sci Transl Med; 2015 May; 7(288):288ra77. PubMed ID: 25995223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxy group requirement for halofuginone-dependent inhibition of muscle fibrosis and improvement of histopathology in the mdx mouse model for Duchenne muscular dystrophy.
    Wellner G; Mordechay S; Evans P; Genin O; Pines M; Halevy O
    Histol Histopathol; 2019 Jul; 34(7):791-801. PubMed ID: 30628720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATP-directed capture of bioactive herbal-based medicine on human tRNA synthetase.
    Zhou H; Sun L; Yang XL; Schimmel P
    Nature; 2013 Feb; 494(7435):121-4. PubMed ID: 23263184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Halofuginone improves muscle-cell survival in muscular dystrophies.
    Bodanovsky A; Guttman N; Barzilai-Tutsch H; Genin O; Levy O; Pines M; Halevy O
    Biochim Biophys Acta; 2014 Jul; 1843(7):1339-47. PubMed ID: 24703880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Synthesis of the Efficient Anti-Coccidial Drug Halofuginone Hydrobromide.
    Zhang J; Yao Q; Liu Z
    Molecules; 2017 Jun; 22(7):. PubMed ID: 28665346
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemical synthesis of febrifugine and analogues.
    Smullen S; McLaughlin NP; Evans P
    Bioorg Med Chem; 2018 May; 26(9):2199-2220. PubMed ID: 29681487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Halofuginone promotes satellite cell activation and survival in muscular dystrophies.
    Barzilai-Tutsch H; Bodanovsky A; Maimon H; Pines M; Halevy O
    Biochim Biophys Acta; 2016 Jan; 1862(1):1-11. PubMed ID: 26454207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of halofuginone lactate on treatment and prevention of lamb cryptosporidiosis: an extensive field trial.
    Giadinis ND; Papadopoulos E; Panousis N; Papazahariadou M; Lafi SQ; Karatzias H
    J Vet Pharmacol Ther; 2007 Dec; 30(6):578-82. PubMed ID: 17991227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Effects of Halofuginone Enantiomers on Muscle Fibrosis and Histopathology in Duchenne Muscular Dystrophy.
    Mordechay S; Smullen S; Evans P; Genin O; Pines M; Halevy O
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Halofuginone inhibits Smad3 phosphorylation via the PI3K/Akt and MAPK/ERK pathways in muscle cells: effect on myotube fusion.
    Roffe S; Hagai Y; Pines M; Halevy O
    Exp Cell Res; 2010 Apr; 316(6):1061-9. PubMed ID: 20060825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of Halofuginone in the amelioration of radiation induced-lung fibrosis.
    Yavas G; Calik M; Calik G; Yavas C; Ata O; Esme H
    Med Hypotheses; 2013 Apr; 80(4):357-9. PubMed ID: 23352286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and in vitro antileishmanial efficacy of novel quinazolinone derivatives.
    Prinsloo IF; Zuma NH; Aucamp J; N'Da DD
    Chem Biol Drug Des; 2021 Feb; 97(2):383-398. PubMed ID: 32914553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the Amino Acid Response Pathway Blunts the Effects of Cardiac Stress.
    Qin P; Arabacilar P; Bernard RE; Bao W; Olzinski AR; Guo Y; Lal H; Eisennagel SH; Platchek MC; Xie W; Del Rosario J; Nayal M; Lu Q; Roethke T; Schnackenberg CG; Wright F; Quaile MP; Halsey WS; Hughes AM; Sathe GM; Livi GP; Kirkpatrick RB; Qu XA; Rajpal DK; Faelth Savitski M; Bantscheff M; Joberty G; Bergamini G; Force TL; Gatto GJ; Hu E; Willette RN
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28487390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.